Zhang Z et al. |
FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury. |
|
J. Cell. Mol. Med. |
pmid:17488479
|
Ubai T et al. |
FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft. |
|
Anticancer Res. |
pmid:17352219
|
Francois M et al. |
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis. |
|
Pharm Stat |
pmid:22888087
|
Huang K et al. |
Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice. |
|
Int J Immunopathol Pharmacol |
pmid:22697071
|
Tedesco-Silva H et al. |
FTY720 and everolimus in de novo renal transplant patients at risk for delayed graft function: results of an exploratory one-yr multicenter study. |
|
Clin Transplant |
pmid:19719728
|
Pin D et al. |
An emulsion restores the skin barrier by decreasing the skin pH and inflammation in a canine experimental model. |
|
J. Comp. Pathol. |
pmid:24975893
|
Suleiman M et al. |
FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury. |
|
Transplant. Proc. |
pmid:15808648
|
Yan S et al. |
Control of intestinal allograft rejection by FTY720 and costimulation blockade. |
|
Transplant. Proc. |
pmid:15808565
|
Galvão VR et al. |
Prolonged administration of FTY720 does not cause renal toxicity in mice. |
|
Transplant. Proc. |
pmid:15808564
|
Kunikata S et al. |
Immunosuppressive action of FTY720 for renal allograft a rat model. |
|
Transplant. Proc. |
pmid:10083517
|